@article{ATM32144,
author = {Shantanu Solanki and Raja Chandra Chakinala and Khwaja Fahad Haq and Muhammad Ali Khan and Alina Kifayat and Katherine Linder and Zubair Khan and Uvesh Mansuri and Khwaja Saad Haq and Christopher Nabors and Wilbert S. Aronow},
title = {Inpatient burden of gastric cancer in the United States},
journal = {Annals of Translational Medicine},
volume = {7},
number = {23},
year = {2019},
keywords = {},
abstract = {Background: Gastric cancer is associated with significant morbidity and mortality. Over one-half of patients have advanced disease at the time of presentation, leading to a significant burden on the healthcare system. Limited epidemiological data exists on national inpatient hospitalization trends. The aim of this study is to determine the inpatient burden of gastric cancer in the United States.
Methods: We analyzed the Nationwide Inpatient Sample (NIS) database for all subjects with the diagnosis of malignant neoplasm of the stomach (ICD-9 code 151.x) as primary diagnosis during the period from 2001–2011. NIS is the largest all-payer inpatient care database in the U.S. Statistical significance of variation in the number of hospitalizations, patient demographics, and comorbidity measures was determined using Cochran-Armitage trend test.
Results: From 2001 to 2011, the number of hospitalizations with the diagnosis of malignant neoplasm of the stomach ranged between 22,430 and 25,371, however, the trend was not significant. Men were always more affected than women with no significant change in overall proportion (P},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/32144}
}